Table 3 RCH provided drugs and antimalarials exposure in pregnant women (n = 994)
Drug group | n (%) |
|---|---|
SP for IPTp | |
Single dose | 211 (21.2) |
Two doses | 735 (73.9) |
Not at all | 48 (4.8) |
Anthelminthic (Mebendazole) | |
Yes | 929 (93.5) |
No | 65 (6.5) |
Iron and Folic acid supplementation | |
Yes | 93 (93.7) |
No | 63 (6.3) |
Patients treated for malaria at least once* | |
Yes | 148 (14.9) |
No | 846 (85.1) |
Types of antimalarials used in treating malaria | |
AL only | 94 (9.5) |
Quinine only | 28 (2.8) |
SP only | 11 (1.1) |
AL and Quinine | 11 (1.1) |
AL and SP | 4 (0.4) |